The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Lillian L. Siu

Princess Margaret Hospital

Toronto

Ontario

M5G2M9 Canada

Canada

[email]@uhn.on.ca

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Princess Margaret Hospital, Toronto, Ontario, M5G2M9 Canada, Canada. 2007 - 2011
  • Division of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, Toronto, Canada. 2003 - 2011
  • Department of Medical Oncology, University of Toronto, Toronto, Canada. 2007

References

  1. Brivanib alaninate for cancer. Diaz-Padilla, I., Siu, L.L. Expert. Opin. Investig. Drugs (2011) [Pubmed]
  2. Early mortality and overall survival in oncology phase I trial participants: can we improve patient selection? Chau, N.G., Florescu, A., Chan, K.K., Wang, L., Chen, E.X., Bedard, P., Oza, A.M., Siu, L.L. BMC. Cancer (2011) [Pubmed]
  3. Phase I study of MGCD0103 given as a three-times-per-week oral dose in patients with advanced solid tumors. Siu, L.L., Pili, R., Duran, I., Messersmith, W.A., Chen, E.X., Sullivan, R., MacLean, M., King, S., Brown, S., Reid, G.K., Li, Z., Kalita, A.M., Laille, E.J., Besterman, J.M., Martell, R.E., Carducci, M.A. J. Clin. Oncol. (2008) [Pubmed]
  4. Phase I/II trial of erlotinib and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Princess Margaret Hospital phase II consortium and National Cancer Institute of Canada Clinical Trials Group Study. Siu, L.L., Soulieres, D., Chen, E.X., Pond, G.R., Chin, S.F., Francis, P., Harvey, L., Klein, M., Zhang, W., Dancey, J., Eisenhauer, E.A., Winquist, E. J. Clin. Oncol. (2007) [Pubmed]
  5. Promising new targeted agents in head and neck cancer. Siu, L.L. Int. J. Radiat. Oncol. Biol. Phys. (2007) [Pubmed]
  6. Phase I trial of sorafenib and gemcitabine in advanced solid tumors with an expanded cohort in advanced pancreatic cancer. Siu, L.L., Awada, A., Takimoto, C.H., Piccart, M., Schwartz, B., Giannaris, T., Lathia, C., Petrenciuc, O., Moore, M.J. Clin. Cancer Res. (2006) [Pubmed]
  7. Enrollment of older patients in cancer treatment trials in Canada: why is age a barrier?. Yee, K.W., Pater, J.L., Pho, L., Zee, B., Siu, L.L. J. Clin. Oncol. (2003) [Pubmed]
 
WikiGenes - Universities